Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 45,607 |
|
|||||
| News | - | ||||||
| Day High | 1.82 | Low High |
|||||
| Day Low | 1.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Virax Biolabs Group Ltd | VRAX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0245 | -1.35% | 1.7855 | 10:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.77 | 1.75 | 1.82 | 1.81 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 233 | 45,607 | $ 1.77 | $ 80,856 | - | 0.60 - 4.599 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:16:56 | 42 | $ 1.77 | USD |
Virax Biolabs Group Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.74M | 1.56M | - | 9k | -5.46M | -3.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Virax Biolabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRAX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.65 | 2.00 | 1.53 | 1.78 | 544,187 | 0.1355 | 8.21% |
| 1 Month | 0.84 | 2.80 | 0.75 | 1.94 | 4,600,400 | 0.9455 | 112.56% |
| 3 Months | 0.78 | 2.80 | 0.60 | 1.92 | 1,525,725 | 1.01 | 128.91% |
| 6 Months | 1.46 | 2.80 | 0.60 | 1.86 | 784,300 | 0.3255 | 22.29% |
| 1 Year | 4.506 | 4.599 | 0.60 | 2.08 | 466,390 | -2.72 | -60.38% |
| 3 Years | 200.00 | 290.00 | 0.60 | 35.44 | 1,114,011 | -198.21 | -99.11% |
| 5 Years | 200.00 | 290.00 | 0.60 | 35.44 | 1,114,011 | -198.21 | -99.11% |
Virax Biolabs Description
| Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. |
